224 related articles for article (PubMed ID: 24989433)
21. A FluoPol-ABPP PAD2 high-throughput screen identifies the first calcium site inhibitor targeting the PADs.
Lewallen DM; Bicker KL; Madoux F; Chase P; Anguish L; Coonrod S; Hodder P; Thompson PR
ACS Chem Biol; 2014 Apr; 9(4):913-21. PubMed ID: 24467619
[TBL] [Abstract][Full Text] [Related]
22. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
Darrah E; Rosen A; Giles JT; Andrade F
Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
[TBL] [Abstract][Full Text] [Related]
23. Small molecule activates citrullination through targeting PAD2.
Zhang X; Shen M; Zhu H; Zhang J; Yang M; Su K; Zhang Y; Fu W; Ke X; Qu Y
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220248. PubMed ID: 37778388
[TBL] [Abstract][Full Text] [Related]
24. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
25. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
26. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
27. GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells.
Khan SA; Edwards BS; Muth A; Thompson PR; Cherrington BD; Navratil AM
Mol Endocrinol; 2016 Oct; 30(10):1081-1091. PubMed ID: 27603413
[TBL] [Abstract][Full Text] [Related]
28. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
29. Microglial expression of peptidylarginine deiminase 2 in the prenatal rat brain.
Asaga H; Ishigami A
Cell Mol Biol Lett; 2007; 12(4):536-44. PubMed ID: 17579814
[TBL] [Abstract][Full Text] [Related]
30. Molecular Mechanism of Protein Arginine Deiminase 2: A Study Involving Multiple Microsecond Long Molecular Dynamics Simulations.
Cicek E; Monard G; Sungur FA
Biochemistry; 2022 Jul; 61(13):1286-1297. PubMed ID: 35737372
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity.
Ranaivoson FM; Bande R; Cardaun I; De Riso A; Gärtner A; Loke P; Reinisch C; Vogirala P; Beaumont E
IUCrJ; 2024 May; 11(Pt 3):395-404. PubMed ID: 38656308
[TBL] [Abstract][Full Text] [Related]
32. PAD2-mediated citrullination of Fibulin-5 promotes elastogenesis.
Sun B; Tomita B; Salinger A; Tilvawala RR; Li L; Hakami H; Liu T; Tsoyi K; Rosas IO; Reinhardt DP; Thompson PR; Ho IC
Matrix Biol; 2021 Aug; 102():70-84. PubMed ID: 34274450
[TBL] [Abstract][Full Text] [Related]
33. Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.
Jang B; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
Prion; 2013; 7(1):42-6. PubMed ID: 23022892
[TBL] [Abstract][Full Text] [Related]
34. Development of a Selective Inhibitor of Protein Arginine Deiminase 2.
Muth A; Subramanian V; Beaumont E; Nagar M; Kerry P; McEwan P; Srinath H; Clancy K; Parelkar S; Thompson PR
J Med Chem; 2017 Apr; 60(7):3198-3211. PubMed ID: 28328217
[TBL] [Abstract][Full Text] [Related]
35. PAD2 dysregulation and aberrant protein citrullination feature prominently in reactive astrogliosis and myelin protein aggregation in sporadic ALS.
Yusuf IO; Parsi S; Ostrow LW; Brown RH; Thompson PR; Xu Z
Neurobiol Dis; 2024 Mar; 192():106414. PubMed ID: 38253209
[TBL] [Abstract][Full Text] [Related]
36. Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).
Bonilha VL; Shadrach KG; Rayborn ME; Li Y; Pauer GJ; Hagstrom SA; Bhattacharya SK; Hollyfield JG
Exp Eye Res; 2013 Jun; 111():71-8. PubMed ID: 23562679
[TBL] [Abstract][Full Text] [Related]
37. Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis.
Bhattacharya SK; Crabb JS; Bonilha VL; Gu X; Takahara H; Crabb JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2508-14. PubMed ID: 16723463
[TBL] [Abstract][Full Text] [Related]
38. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
Damgaard D; Senolt L; Nielsen CH
Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
[TBL] [Abstract][Full Text] [Related]
39. Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis.
Tian Y; Qu S; Alam HB; Williams AM; Wu Z; Deng Q; Pan B; Zhou J; Liu B; Duan X; Ma J; Mondal S; Thompson PR; Stringer KA; Standiford TJ; Li Y
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 33055424
[TBL] [Abstract][Full Text] [Related]
40. Mechanical stretching elevates peptidyl arginine deiminase 2 expression in astrocytes.
Algeciras ME; Takahara H; Bhattacharya SK
Curr Eye Res; 2008 Nov; 33(11):994-1001. PubMed ID: 19085382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
